Law360, New York (September 15, 2009) -- Shire LLC has agreed to put down its dukes and enter a licensing deal with Teva Pharmaceutical Industries Ltd. in a patent infringement dispute over Carbatrol, paving the way for Teva to introduce a generic version of the epilepsy drug.
Shire notified Judge Miram G. Cedarbaum of the U.S. District Court for the Southern District of New York on Monday of a settlement, after more than two years of litigation...
